241 related articles for article (PubMed ID: 17131324)
1. Different types of postmenopausal hormone therapy and mammographic density in Norwegian women.
Bremnes Y; Ursin G; Bjurstam N; Lund E; Gram IT
Int J Cancer; 2007 Feb; 120(4):880-4. PubMed ID: 17131324
[TBL] [Abstract][Full Text] [Related]
2. Postmenopausal hormone therapy with estradiol and norethisterone acetate and mammographic density: findings from a cross-sectional study among Norwegian women.
Stuedal A; Ma H; Bjørndal H; Ursin G
Climacteric; 2009 Jun; 12(3):248-58. PubMed ID: 19387884
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor and mammographic density in postmenopausal Norwegian women.
Bremnes Y; Ursin G; Bjurstam N; Rinaldi S; Kaaks R; Gram IT
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):57-62. PubMed ID: 17220332
[TBL] [Abstract][Full Text] [Related]
4. Hormone therapy use and mammographic density in postmenopausal Norwegian women.
Couto E; Qureshi SA; Hofvind S; Hilsen M; Aase H; Skaane P; Vatten L; Ursin G
Breast Cancer Res Treat; 2012 Feb; 132(1):297-305. PubMed ID: 22052325
[TBL] [Abstract][Full Text] [Related]
5. Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women.
Bremnes Y; Ursin G; Bjurstam N; Rinaldi S; Kaaks R; Gram IT
Int J Cancer; 2007 Dec; 121(11):2506-11. PubMed ID: 17657735
[TBL] [Abstract][Full Text] [Related]
6. Different measures of smoking exposure and mammographic density in postmenopausal Norwegian women: a cross-sectional study.
Bremnes Y; Ursin G; Bjurstam N; Gram IT
Breast Cancer Res; 2007; 9(5):R73. PubMed ID: 17963507
[TBL] [Abstract][Full Text] [Related]
7. Use of hormone therapy and risk of breast cancer detected at screening and between mammographic screens.
Hofvind S; Møller B; Thoresen S; Ursin G
Int J Cancer; 2006 Jun; 118(12):3112-7. PubMed ID: 16395702
[TBL] [Abstract][Full Text] [Related]
8. Endogenous sex hormone levels and mammographic density among postmenopausal women.
Tamimi RM; Hankinson SE; Colditz GA; Byrne C
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2641-7. PubMed ID: 16284390
[TBL] [Abstract][Full Text] [Related]
9. Prenatal and perinatal correlates of adult mammographic breast density.
Cerhan JR; Sellers TA; Janney CA; Pankratz VS; Brandt KR; Vachon CM
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1502-8. PubMed ID: 15941963
[TBL] [Abstract][Full Text] [Related]
10. Alcohol intake and mammographic density in postmenopausal Norwegian women.
Qureshi SA; Couto E; Hofvind S; Wu AH; Ursin G
Breast Cancer Res Treat; 2012 Feb; 131(3):993-1002. PubMed ID: 21993860
[TBL] [Abstract][Full Text] [Related]
11. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
[TBL] [Abstract][Full Text] [Related]
12. Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method.
Eilertsen AL; Karssemeijer N; Skaane P; Qvigstad E; Sandset PM
BJOG; 2008 May; 115(6):773-9. PubMed ID: 18355366
[TBL] [Abstract][Full Text] [Related]
13. Mammographic density, response to hormones, and breast cancer risk.
Boyd NF; Melnichouk O; Martin LJ; Hislop G; Chiarelli AM; Yaffe MJ; Minkin S
J Clin Oncol; 2011 Aug; 29(22):2985-92. PubMed ID: 21709206
[TBL] [Abstract][Full Text] [Related]
14. Use of hormone therapy and isoflavones and mammographic density in Spain.
Isidoro B; Lope V; Whelan D; Pedraz C; Sánchez-Contador C; Santamariña C; Moreo P; Vidal C; Salas-Trejo D; Ederra M; Aragonés N; Pérez-Gómez B; Pollán M
Menopause; 2016 May; 23(5):556-64. PubMed ID: 26731688
[TBL] [Abstract][Full Text] [Related]
15. The effect of low dose hormone therapy on mammographic breast density.
Christodoulakos GE; Lambrinoudaki IV; Vourtsi AD; Vlachou S; Creatsa M; Panoulis KP; Botsis D
Maturitas; 2006 Apr; 54(1):78-85. PubMed ID: 16198519
[TBL] [Abstract][Full Text] [Related]
16. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
Tamimi RM; Byrne C; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2007 Aug; 99(15):1178-87. PubMed ID: 17652278
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of leptin and mammographic density among postmenopausal women: a cross-sectional study.
Stuedal A; Ursin G; Veierød MB; Bremnes Y; Reseland JE; Drevon CA; Gram IT
Breast Cancer Res; 2006; 8(5):R55. PubMed ID: 17010200
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of enterolactone and percentage mammographic density among postmenopausal women.
Stuedal A; Gram IT; Bremnes Y; Adlercreutz H; Veierød MB; Ursin G
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2154-9. PubMed ID: 16172225
[TBL] [Abstract][Full Text] [Related]
19. Digitized assessment of mammographic breast density--effects of continuous combined hormone therapy, tibolone and black cohosh compared to placebo.
Lundström E; Hirschberg AL; Söderqvist G
Maturitas; 2011 Dec; 70(4):361-4. PubMed ID: 21958943
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal trends in mammographic percent density and breast cancer risk.
Vachon CM; Pankratz VS; Scott CG; Maloney SD; Ghosh K; Brandt KR; Milanese T; Carston MJ; Sellers TA
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):921-8. PubMed ID: 17507617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
